Farmax India Limited reported unaudited earnings results for the second quarter and six months ended September 30, 2013. For the quarter, the company's net sales/income from operations was INR 4.96 million compared to INR 17.03 million a year ago. Loss from operations before other income and exceptional items was INR 4.09 million compared to INR 2.93 million a year ago. Loss from ordinary activities before tax was INR 3.98 million compared to INR 2.93 million a year ago. Net loss was INR 3.98 million compared to INR 2.92 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.10 compared to INR 0.07 a year ago.

For the six months, the company's net sales/income from operations was INR 8.71 million compared to INR 42.11 million a year ago. Loss from operations before other income and exceptional items was INR 6.61 million compared to INR 2.77 million a year ago. Loss from ordinary activities before tax was INR 6.43 million compared to INR 2.69 million a year ago. Net loss was INR 6.43 million compared to INR 2.69 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.16 compared to INR 0.04 a year ago.